Rasagiline Tablets 1.0 mg (Rasagiline Mesylate)

Adult dose

This medicine is administered orally to adults once daily as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy with a dopamine agonist: Administer 1mg orally once daily. 2) Adjunctive therapy with levodopa: The recommended initial dose for patients taking levodopa is 0.5mg once daily. If well tolerated and the clinical response is insufficient, the dose may be increased to 1mg once daily. This medicine may be taken with or without food.

This medication should not be administered to certain patients. Individuals allergic to any of the ingredients should not take it. It should not be used if currently taking or has discontinued other MAO inhibitors within the last 2 weeks. It should also be avoided in patients currently taking or who have stopped taking the analgesic pethidine within the last 2 weeks. Patients taking tramadol or dextromethorphan should avoid using this medication as well. Patients with moderate to severe liver impairment should not take this medication. While taking this medication, various side effects may occur. Commonly reported side effects include headaches, dizziness, nausea, insomnia, and musculoskeletal pain. Symptoms such as depression, hallucinations, dermatitis, rhinitis, fever, and fatigue may also occur. Rarely, myocardial infarction, cerebrovascular accidents, and cardiac-related abnormal symptoms have been reported. This medication is used for the treatment of Parkinson's disease and may cause movement disorders or dopamine-related side effects. Particularly, when taken with other dopaminergic drugs, low blood pressure or sedation may worsen, therefore caution is advised. Drowsiness or sudden sleep may occur while driving or operating machinery, so care should be taken. This medication has many drug interactions, so it is essential to consult with a healthcare professional when taken together with other MAO inhibitors, antidepressants, analgesics, cold medications, or CYP1A2 inhibitors. Smokers need to be aware that the effectiveness of this medication may be reduced. Pregnant women should exercise caution when taking this medication, and those who are nursing should also be cautious as the drug may be transferred through breast milk. The safety and efficacy in children under 18 years old have not been established, so it is advisable not to use it in this age group. Older adults aged 65 years and above can take it without special dosage adjustment. In case of overdose, symptoms such as severe hypertension, serotonin syndrome, or mild mania may occur, and immediate medical attention should be sought for appropriate treatment. This medication should be stored between 1°C and 25°C, in a secure place out of reach of children. Transferring it to another container can cause degradation of quality or accidents, so it must be avoided.

• influenza
• skin cancer
• leukopenia
• allergy
• appetite loss
• depression
• hallucinations
• headache
• cerebrovascular accident
• conjunctivitis

This medication should be stored in a sealed container to avoid exposure to air, and it is best stored in a cool place between 1°C and 25°C. This storage will help maintain the medication's effectiveness for a longer duration.

Appearance

White round tablet

Package unit

30 tablets/bottle